Bryn Mawr Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
7,707
-176
| -2% | -$32.7K | 0.08% | 174 |
|
|
2025
Q1 | $1.65M | Buy |
7,883
+729
| +10% | +$153K | 0.1% | 159 |
|
|
2024
Q4 | $1.27M | Buy |
7,154
+306
| +4% | +$54.4K | 0.07% | 190 |
|
|
2024
Q3 | $1.35M | Buy |
6,848
+436
| +7% | +$86.1K | 0.07% | 189 |
|
|
2024
Q2 | $1.1M | Sell |
6,412
-8,651
| -57% | -$1.49M | 0.06% | 205 |
|
|
2024
Q1 | $1.16M | Buy |
15,063
+8,673
| +136% | +$666K | 0.07% | 209 |
|
|
2023
Q4 | $990K | Sell |
6,390
-248
| -4% | -$38.4K | 0.06% | 214 |
|
|
2023
Q3 | $989K | Buy |
6,638
+4,684
| +240% | +$698K | 0.06% | 209 |
|
|
2023
Q2 | $263K | Sell |
1,954
-410
| -17% | -$55.2K | 0.02% | 256 |
|
|
2023
Q1 | $377K | Sell |
2,364
-1,822
| -44% | -$290K | 0.04% | 217 |
|
|
2022
Q4 | $676K | Buy |
4,186
+1,222
| +41% | +$197K | 0.07% | 185 |
|
|
2022
Q3 | $398K | Buy |
2,964
+119
| +4% | +$16K | 0.14% | 99 |
|
|
2022
Q2 | $436K | Sell |
2,845
-620
| -18% | -$95K | 0.14% | 103 |
|
|
2022
Q1 | $562K | Buy |
+3,465
| New | +$562K | 0.16% | 97 |
|
|
2021
Q3 | – | Sell |
-1,877
| Closed | -$211K | – | 102 |
|
|
2021
Q2 | $211K | Sell |
1,877
-89
| -5% | -$10K | 0.1% | 93 |
|
|
2021
Q1 | $213K | Buy |
+1,966
| New | +$213K | 0.1% | 89 |
|